<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-id>
      <journal-id journal-id-type="publisher-id">.</journal-id>
      <journal-title>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-title><issn pub-type="ppub">2621-4814</issn><issn pub-type="epub">2621-4814</issn><publisher>
      	<publisher-name>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.33084/bjop.v5i2.3169</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group><subject>Anti-Inflammatory</subject><subject>Analgesic</subject><subject>Musa balbisiana peels</subject></subj-group>
      </article-categories>
      <title-group>
        <article-title>Anti-Inflammatory and Analgesic Activity of Musa balbisiana Peels In Vivo</article-title><subtitle>Anti-Inflammatory and Analgesic Activity of Musa balbisiana Peels In Vivo</subtitle></title-group>
      <contrib-group><contrib contrib-type="author">
	<name name-style="western">
	<surname>Sandhiutami</surname>
		<given-names>Ni Made Dwi</given-names>
	</name>
	<aff>Department of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta Capital Special Region, Indonesia</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Khairani</surname>
		<given-names>Sondang</given-names>
	</name>
	<aff>Department of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta Capital Special Region, Indonesia</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Dewi</surname>
		<given-names>Rika Sari</given-names>
	</name>
	<aff>Department of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta Capital Special Region, Indonesia</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Hakim</surname>
		<given-names>Zainur Rahman</given-names>
	</name>
	<aff>Department of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta Capital Special Region, Indonesia</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Pradani</surname>
		<given-names>Anita Rahmi</given-names>
	</name>
	<aff>Department of Pharmacy, Universitas Pancasila, South Jakarta, Jakarta Capital Special Region, Indonesia</aff>
	</contrib></contrib-group>		
      <pub-date pub-type="ppub">
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>05</month>
        <year>2022</year>
      </pub-date>
      <volume>5</volume>
      <issue>2</issue>
      <permissions>
        <copyright-statement>© 2022 Ni Made Dwi Sandhiutami, Sondang Khairani, Rika Sari Dewi, Zainur Rahman Hakim, Anita Rahmi Pradani</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-sa/4.0/"><p>This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.</p></license>
      </permissions>
      <related-article related-article-type="companion" vol="2" page="e235" id="RA1" ext-link-type="pmc">
			<article-title>Anti-Inflammatory and Analgesic Activity of Musa balbisiana Peels In Vivo</article-title>
      </related-article>
	  <abstract abstract-type="toc">
		<p>
			Musa balbisiana Peels (MBP) contains high levels of flavonoids, alkaloids, tannins, saponins, and triterpenoids. Flavonoids function to slow down the inflammatory process by inhibiting the arachidonic acid, forming prostaglandins, and releasing histamine. This study aimed to examine the anti-inflammatory and analgesic effects of MBP decoction. This study used the Winter method for anti-inflammatory assay by induction of carrageenan on the soles of rat's feet and Sigmund's method for analgesic assay with intraperitoneal induction of acetic acid in mice. Group I as a negative control, group II as a positive control with diclofenac sodium, group III as a low dose (200 mg/kg BW of MBP), group IV as a medium dose (400 mg/kg BW of MBP), and group V as a high dose (800 mg/kg BW of MBP decoction). The percentage of inhibition in the anti-inflammatory test in rats for groups II, III, IV, and V was 34.43, 17.68, 25.53, and 25.4, and the percentage of effectiveness for the anti-inflammatory test, respectively, was 51.35, 74.15, and 74.01. The results of the percentage inhibition of the analgesic test in mice for groups II, III, IV, and V were 55.25, 38.52, 44.53, and 49.31, and the percentage of effectiveness for the analgesic test, respectively, followed by 69.71, 80.59, and 89.24. Based on the results, it can be concluded that the decoction of the MBP has an anti-inflammatory and analgesic effect.
		</p>
		</abstract>
    </article-meta>
  </front>
  <body><sec>
			<title>INTRODUCTION</title>
				<p >Inflammation
is a complex biological response of vascular tissue to noxious stimuli such as
pathogens, damaged body cells, or irritants<bold>1</bold>. Inflammation is triggered by releasing chemical mediators from damaged
tissues and cell migration<bold>2</bold>. Pain, redness, swelling, and tissue and organ dysfunction are signs of
inflammation<bold>3</bold>. This is a protective response made by the body against tissue damage
caused by various stimuli<bold>4</bold>. In such cases, their defense reactions may cause progressive tissue
injury, and anti-inflammatory or immunosuppressive drugs may be required to
modulate the inflammatory process<bold>5</bold>.</p><p >Pain is the
most common symptom when inflammation occurs and can reduce the quality of
life. Pain is an unpleasant sensory and emotional feeling associated with
tissue damage<bold>6</bold>. Pain is often described as either noxious (noxious, protopathic) or
harmless (non-noxious, epicritic), for example, light touch, warmth, or light
pressure. Most people feel disturbed, uncomfortable, and tormented by the pain<bold>7</bold>. Many people cannot stand it and try to relieve pain by using painkillers
or analgesics. Many different types of therapy have been developed to reduce
pain caused by inflammation. In controlling inflammation and pain, drugs that
can inhibit the disease are needed, so anti-inflammatory and analgesic drugs
are needed, better known as anti-inflammatory and analgesic drugs (NSAIDs)<bold>8</bold>. The principal mechanism of action of NSAIDs, as analgesics, is the
blockade of prostaglandin synthesis through cyclooxygenase inhibition (COX-1
and COX-2 enzymes) so that the production of PGI2 (prostacyclin) by COX-1 as a
gastroprotective is also inhibited<bold>9</bold>. So if the therapy for pain and anti-inflammatory is carried out for a
long time and requires high doses of drugs, that can be affected by side
effects on the stomach<bold>10</bold>.</p><p >Many herbal
plants have been developed and have therapeutic effects for inflammation and
pain, such as modern allopathic drugs with a single active substance with a
single target pathway of action. Herbal medicines consist of various active
molecules that work synergistically with various action targets<bold>11</bold>. The utilization of natural resources in the form of plants has long been
used to cure diseases<bold>12</bold>. One of the plants used in medicine is Musa balbisiana (one type of
banana). Musa balbisiana developing research, especially in
terms of pharmacology and phytochemicals, is based on indications of medicinal
plants that some people with empirically proven efficacy have used<bold>13</bold>.</p><p >Musa balbisiana peels (MBP; <bold>Figure 1</bold>) have not been used optimally as traditional
medicine, even though the fruit is widely used and consumed in the community.
The use of this peel can undoubtedly reduce the organic waste of the MBP. The
MBP contains high flavonoid content. Based on the results of the phytochemical
screening conducted, it was known that the MBP contained flavonoids, alkaloids,
tannins, saponins, and triterpenoids<bold>14</bold>. The GC-MS analysis showed that the major component of M. balbisiana
extract was difluroisocyanotophosphine<bold>15</bold>. By inhibiting the arachidonic acid metabolic pathway, the formation of
prostaglandins, and the release of histamine, flavonoids function as an
anti-inflammatory or slow down the inflammatory process<bold>16</bold>. Flavonoids are anti-inflammatory agents because flavonoids in the body
act to inhibit lipoxygenase enzymes, the role in leukotriene biosynthesis<bold>17</bold>.</p><p ><bold>Figure</bold><bold>1</bold><bold>.</bold> Musa balbisiana fruit</p><p >In addition to
inhibiting the metabolism of arachidonic acid by reducing prostaglandins production,
flavonoids also inhibit the secretion of lysosomal enzymes, which are
inflammatory mediators. Inhibition of these inflammatory mediators can inhibit
the proliferation of the inflammatory process<bold>18</bold>. Saponins are thought to interact with many membrane lipids. Membrane
lipids such as phospholipids are precursors of prostaglandins and other
inflammatory mediators. Saponins are thought to inhibit the increase in
vascular permeability so that edema as a sign of inflammation does not occur<bold>19</bold>. Tannins have antioxidant activity, and antioxidants act as an
anti-inflammatory in various ways, including inhibiting the production of O2 oxidants by neutrophils, monocytes, and macrophages<bold>20</bold>. Based on these things, the authors are interested in further researching
the anti-inflammatory effect that will be tested using the Winter method and
the analgesic effect that will be tested using the Sigmund method of MBP decoction. The community has widely used this decoction method to
manufacture traditional medicine because the extraction process is easy to do
and does not require special tools. The
anti-inflammatory and analgesic research carried out using MBP decoction aims to prove that the MBP has anti-inflammatory and analgesic
effects.</p>
			</sec><sec>
			<title>MATERIALS AND METHODS</title>
				<p ><bold>Materials</bold></p><p >Musa
Balbisiana peels
fruit used in this study was obtained from Trirahayu Village, Negeri Katon
District, Pesawaran Regency, Lampung Province, Indonesia. The experiment used
Sprague Dawley (SD) male white rats aged 2-3 months with a bodyweight of
150-200 g as an anti-inflammatory test, and the Deutsche Denken Yoken strain
male white mice aged 2-3 months old and weighed 25-30 g as an analgesic test,
developed at the Non-Ruminant and Animal Hope Laboratory, Faculty of Animal
Husbandry, IPB University. Other materials include diclofenac sodium, 0.5% CMC
sodium, 1% carrageenan, 3% acetic acid, aquadest, feeding tube, stopwatch, and
plethysmometer.</p><p ><bold>Methods</bold></p><p >Plant determination</p><p >Plant
samples identified as M. balbisiana were determined at Herbarium
Bogoriense, Botany, Indonesian Institute of Sciences, Research Center for
Biology, Cibinong Science Center, Bogor, Indonesia, with number
353/IPH.1.01/If.07/II/2020.</p><p >MBP decoction
preparations</p><p >As much
as 10 g of MBP powder was added with 200 mL of water, then it was heated until
the volume was half of the initial volume with occasional stirring and then
filtered through a filter heat sufficiently to obtain the desired volume of 100
mL.</p><p >Anti-inflammatory
test</p><p >This research was
carried out after obtaining ethical approval number 101/II/2021/KEPK from the
Health Research Ethics Committee Universitas Pembangunan Nasional Veteran
Jakarta. All actions were taken by minimizing pain and suffering in
experimental animals<bold>21</bold>. An
anti-inflammatory test was carried out using the Winter method to form edema on
the paw of rats<bold>22</bold>. Before the
experiment was carried out on rats, rats fasted for ± 18 hours while still
being given water. The rats were weighed on the day of testing; 25 rats were
taken at random and divided into five groups, respectively, with five rats
each. Group I was a control (-) and given aquadest + 0.2 mL 1% carrageenan;
Group II was the control (+) and was given 8.02 mg/200 g BW diclofenac sodium +
0.2 mL 1% carrageenan; while Groups III, IV, and V were the dose group that was
given orally MBP decoction of 200; 400; and 800 mg/kg BW, respectively, and
given 0.2 mL 1% carrageenan on the soles of the feet rat. Before being treated,
measure the initial volume of the rat's paws by dipping the rat's paws into the
plethysmometer. In the treatment of each anti-inflammatory test group, the rats
were given the preparation of the test substance orally according to the dose
of each treatment group. Thirty minutes later, the rat's paws were induced with
0.2 mL 1% carrageenan intraplantar continued to measure the volume of rat paw
edema every hour for five hours. The calculations for area under the curve
(AUC), percentage of anti-inflammatory (% antiinflammatory), and percentage of
anti-inflammatory effectiveness (% effectiveness) occurring in the test group
were presented in <bold>Equations 1</bold>to<bold>3</bold><bold>.</bold></p><p >
 
 
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 

 
 …
[1]</p><p >
 
 …
[2]</p><p >
 
 …
[3]</p><p >Vn : Volume of rat paw at
hour/minute n </p><p >Vn-1 : Volume of rat paw at
hour/minute (n-1)</p><p >tn : Hour n or minute n</p><p >tn-1 : Hour (n-1) or minute
(n-1)</p><p >Analgesic test</p><p >The
analgesic test was performed using the Sigmund method<bold>23</bold>. Before the
experiment was conducted on mice, the mice fasted for ± 18 hours while still
being given water. On the test day, the weight of the mice was weighed, and 25
mice were taken at random and divided into five groups, with five mice each.
Group I was a control (-) and was given aquadest + 0.2 mL/20 g BW 3% acetic
acid; Group II was a control (+) and was given
81.16 mg/20 g BW diclofenac sodium + 0.2 mL/20 g BW 3% acetic acid;
while Groups III, IV, and V were the dose group that was given orally MBP decoction
of 200; 400; and 800 mg/kg BW, respectively, and given 0.2 mL/20 g BW 3% acetic
acid. In the treatment of each analgesic test group, mice were given the test
substance orally by the treatment dose of each group. Thirty minutes later, the
mice were induced with 0.2 mL/20 g/BW 3% acetic acid intraperitoneally. Then
the mice were placed in the cage; after the administration of acetic acid, the
mice would give a writhing response which was
indicated by moving a pair of front legs that were pulled forward and a pair of
hind legs that were pulled back and rubbing their stomach against the bottom of
the cage. The mice were observed, then the number of stretches shown by the
mice was recorded every five minutes for an hour. The calculations for AUC were
given in <bold>Equation 4</bold>, while % antiinflammatory and %
effectiveness was calculated using <bold>Equations 2</bold> and <bold>3</bold>.</p><p >
 
 … [4]</p><p >∑n : Number of mice writhing
in hours/minute n</p><p >∑n-1 : Number of mice writhing in
hours/minute (n-1)</p><p >tn : Hour n or minute n</p><p >tn-1 : Hour (n-1) or minute
(n-1)</p><p >Data analysis</p><p >The AUC values of
data ​​between
each treatment group were analyzed using the SPSS® Statistical
Analysis version 20. If the data on AUC values ​​in all treatments
had a normal and homogeneous distribution, the analysis would continue using
one-way ANOVA (Analysis of Variance). If the results of the ANOVA test show
that there is a statistically significant difference in each treatment, then
the analysis will continue using the LSD (Least Significant Difference) test
with a significance level of 5% (0.05) to determine whether there is a
difference between each treatment. However, if the AUC value data has no
requirements of a normal distribution and no homogeneity, the test continued
with the Kruskal-Wallis method<bold>24</bold>.</p>
			</sec><sec>
			<title>RESULTS AND DISCUSSION</title>
				<p >Anti-inflammatory
test</p><p >The data on the
average volume of rat paw edema showed that the administration of the test
substance reduced the volume of rat paw edema in the third hour after being
induced by carrageenan. This shows that the ability of the test substance
preparation can inhibit the increase in the volume of edema. The data is
displayed in graphical form, as shown in <bold>Figure 2</bold>. Assessment of the
effectiveness of anti-inflammatory drugs and looking at the increase and
decrease in the volume of edema on the rat's paw can also be seen from the
calculation of AUC. The greater the AUC value, the less effective an
anti-inflammatory drug is. The results of the average AUC value in all
treatment groups, the negative control AUC value was higher than all other test
preparation groups. This indicates that carrageenan can induce the formation of
edema on the soles of the rats' feet.</p><p >The AUC value of the
test preparation and the positive control group was lower than the AUC value of
the negative control group, indicating that the whole group of the test
substance for the MBP decoction and the positive control had an
anti-inflammatory effect. Based on the three decoction doses, it was found that
the stew with a dose of 800 mg/kg BW was better at inhibiting the formation of
edema in the soles of the rats' feet, as indicated by the lowest average AUC
value compared to the other two groups (<bold>Table I</bold>). Based on the
statistical test, it was found that there was a significant difference between
the negative and the positive groups, and the three doses showed a decrease in
edema volume compared to the negative group (p&lt;α = 0.05). There was a
significant difference between the positive group and the dose group of MBP
200; 400; and 800 mg/kg BW, which indicated that the volume of edema in the
positive group was smaller than that of the three-dose groups. There was no
significant difference between the three-dose groups (p&lt;α = 0.05).</p><p ><bold>Figure</bold><bold>2</bold><bold>.</bold> Correlation between time and
the average volume of rat paw edema</p><p ><bold>Tab</bold><bold>le</bold><bold>I</bold><bold>.</bold> The AUC
values in the anti-inflammatory test</p>

<table-wrap><label>Table</label><table>
 <tr>
  <td>
  Groups
  </td>
  
  <td>
  Value of AUC on rats (mL.hours)
  </td>
  
  <td>
  Average ± SD
  </td>
  
 </tr>
 <tr>
  
  <td>
  1
  </td>
  
  <td>
  2
  </td>
  
  <td>
  3
  </td>
  
  <td>
  4
  </td>
  
  <td>
  5
  </td>
  
 </tr>
 <tr>
  <td>
  Negative control
  </td>
  
  <td>
  6.74
  </td>
  
  <td>
  7.31
  </td>
  
  <td>
  6.98
  </td>
  
  <td>
  7.06
  </td>
  
  <td>
  6.31
  </td>
  
  <td>
  6.88 ±
  0.38
  </td>
  
 </tr>
 <tr>
  <td>
  Positive control
  </td>
  
  <td>
  4.62
  </td>
  
  <td>
  4.09
  </td>
  
  <td>
  4.50
  </td>
  
  <td>
  4.53
  </td>
  
  <td>
  4.83
  </td>
  
  <td>
  4.51
  ± 0.27
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 200 mg/Kg BW
  </td>
  
  <td>
  5.44
  </td>
  
  <td>
  6.00
  </td>
  
  <td>
  6.25
  </td>
  
  <td>
  4.75
  </td>
  
  <td>
  5.86
  </td>
  
  <td>
  5.66
  ± 0.59
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 400 mg/Kg BW
  </td>
  
  <td>
  5.30
  </td>
  
  <td>
  5.17
  </td>
  
  <td>
  4.93
  </td>
  
  <td>
  4.86
  </td>
  
  <td>
  5.36
  </td>
  
  <td>
  5.12
  ± 0.22
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 800 mg/Kg BW
  </td>
  
  <td>
  5.02
  </td>
  
  <td>
  5.18
  </td>
  
  <td>
  4.93
  </td>
  
  <td>
  5.03
  </td>
  
  <td>
  5.40
  </td>
  
  <td>
  5.13 ±
  0.17
  </td>
  
 </tr>
</table></table-wrap>

<p >Analgesic test</p><p >Data on the average
number of writhing in mice showed a decrease in the number of writhing in the
20th minute after being induced with acetic acid. This indicates the
ability of the test substance to inhibit the increase in the number of writhing
in mice. The data is displayed in graphical form, as shown in <bold>Figure 3</bold>. Assessment of the
effectiveness of analgesic drugs and looking at the increase and decrease in
the number of stretches in mice can also be seen from the AUC value. The
smaller the AUC value, the greater the effectiveness of an analgesic drug. The
results of the average AUC value can be seen that all doses have an analgesic
effect because the negative control AUC value is higher than the positive
control AUC value and other doses, but the 800 mg/kg BW has the lowest AUC
value compared to the group other doses, as shown in <bold>Table II</bold>.</p><p >There was a
significant difference between the negative and positive groups and the three
doses of MBP, which showed a decrease in the number of stretches in the
positive and the three doses compared to the negative groups. There was a
significant difference between the positive and three MBP dose groups, which
showed that the number of stretches of the positive group was smaller than the
three MBP dose groups. There was a significant difference between the MBP group
at a dose of 200 mg/kg BW compared to the MBP group at a dose of 400 and 800
mg/kg BW, which showed the number of stretching of the MBP group at a dose of
200 mg/kg BW was more than that in the MBP group at a dose of 400 and 800 mg/kg
BW. Moreover, there was a significant difference between the MBP group at a
dose of 400 and 800 mg/kg BW, which showed that the MBP group at a dose of 400
mg/kg BW was more stretched than the 800 mg/kg BW group (p&lt;α = 0.05).</p><p ><bold>Figure</bold><bold>3</bold><bold>.</bold> Correlation between time and
the average number of writhing</p><p ><bold>Tab</bold><bold>le</bold><bold>II</bold><bold>.</bold> The AUC values in the analgesic test</p>

<table-wrap><label>Table</label><table>
 <tr>
  <td>
  Groups
  </td>
  
  <td>
  Value of
  AUC on mice (n)
  </td>
  
  <td>
  Average ± SD
  </td>
  
 </tr>
 <tr>
  
  <td>
  1
  </td>
  
  <td>
  2
  </td>
  
  <td>
  3
  </td>
  
  <td>
  4
  </td>
  
  <td>
  5
  </td>
  
 </tr>
 <tr>
  <td>
  Negative control
  </td>
  
  <td>
  732.5
  </td>
  
  <td>
  735
  </td>
  
  <td>
  657.5
  </td>
  
  <td>
  710
  </td>
  
  <td>
  722.5
  </td>
  
  <td>
  711.5
  ± 31.75
  </td>
  
 </tr>
 <tr>
  <td>
  Positive control
  </td>
  
  <td>
  330
  </td>
  
  <td>
  322.5
  </td>
  
  <td>
  332.5
  </td>
  
  <td>
  312.5
  </td>
  
  <td>
  320
  </td>
  
  <td>
  323.5
  ± 8.02
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 200 mg/Kg BW
  </td>
  
  <td>
  430
  </td>
  
  <td>
  450
  </td>
  
  <td>
  432.5
  </td>
  
  <td>
  475
  </td>
  
  <td>
  435
  </td>
  
  <td>
  444.5
  ± 18,74
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 400 mg/Kg BW
  </td>
  
  <td>
  392.5
  </td>
  
  <td>
  395
  </td>
  
  <td>
  390
  </td>
  
  <td>
  420
  </td>
  
  <td>
  407.5
  </td>
  
  <td>
  401.0
  ± 12.57
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 800 mg/Kg BW
  </td>
  
  <td>
  372.5
  </td>
  
  <td>
  355
  </td>
  
  <td>
  372.5
  </td>
  
  <td>
  372.5
  </td>
  
  <td>
  360
  </td>
  
  <td>
  366.5
  ± 8.40
  </td>
  
 </tr>
</table></table-wrap>

<p >Percentage of inhibition
of edema and writhing</p><p >The percentage of
inhibition can be calculated from the average AUC data for the test and
negative control groups, as shown in <bold>Table III</bold>. The positive control had better
inhibition of edema and inhibition of the number of stretches than the test
preparation group. It can also be seen that a decoction dose of 800 mg/kg BW
(analgesic test) had the most significant inhibition of the amount of writhing
compared to other decoction doses and a dose of 400 mg/kg BW (anti-inflammatory
test).</p><p ><bold>Tab</bold><bold>le</bold><bold>III</bold><bold>.</bold> % inhibition of edema and writhing of mice</p><table-wrap><label>Table</label><table>
 <tr>
  <td>
  Groups
  </td>
  
  <td>
  % inhibition
  </td>
  
 </tr>
 <tr>
  
  <td>
  % anti-inflammatory
  </td>
  
  <td>
  % analgesic
  </td>
  
 </tr>
 <tr>
  <td>
  Diclofenac sodium
  </td>
  
  <td>
  34.43
  </td>
  
  <td>
  55.25
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 200 mg/Kg BW
  </td>
  
  <td>
  17.68
  </td>
  
  <td>
  38.52
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 400 mg/Kg BW
  </td>
  
  <td>
  25.53
  </td>
  
  <td>
  44.53
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 800 mg/Kg BW
  </td>
  
  <td>
  25.48
  </td>
  
  <td>
  49.31
  </td>
  
 </tr>
</table></table-wrap><p >Percentage of anti-inflammatory
and analgesic effectiveness</p><p >The percentage of
effectiveness was calculated by comparing the average AUC of the test group
with the average AUC of the positive control (diclofenac sodium), as shown in <bold>Table IV</bold>. The analgesic test
preparation group at a dose of 800 mg/kg BW had better effectiveness as an
analgesic compared to other doses, and the anti-inflammatory test preparation
group at a dose of 400 mg/kg BW had a better anti-inflammatory effect than the
analgesic test preparation group at a dose of 400 mg/kg BW with other doses.</p><p ><bold>Tab</bold><bold>le</bold><bold>IV</bold><bold>.</bold> % anti-inflammatory and analgesic effectiveness</p><table-wrap><label>Table</label><table>
 <tr>
  <td>
  Groups
  </td>
  
  <td>
  %
  effectiveness
  </td>
  
 </tr>
 <tr>
  
  <td>
  %
  anti-inflammatory
  </td>
  
  <td>
  %
  analgesic
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 200 mg/kg BW
  </td>
  
  <td>
  51.35
  </td>
  
  <td>
  69.71
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 400 mg/kg BW
  </td>
  
  <td>
  74.15
  </td>
  
  <td>
  80.59
  </td>
  
 </tr>
 <tr>
  <td>
  MBP 800 mg/kg BW
  </td>
  
  <td>
  74.01
  </td>
  
  <td>
  89.24
  </td>
  
 </tr>
</table></table-wrap><p >The
anti-inflammatory and analgesic research carried out using MBP decoction aims
to prove that the MBP has anti-inflammatory and analgesic effects. In the MBP,
some compounds are efficacious as anti-inflammatory and analgesic. The
compounds contained in the peels of the M. balbisiana are flavonoids
which are thought to have anti-inflammatory and analgesic activity<bold>25</bold>. The method used
for the preparation of preparations is adjusted to the efficacious compounds,
so it is hoped that these compounds are present in the preparations made. The
decoction was chosen in this study because the stew is a method that is easy to
apply, and the solvent is easy to obtain<bold>26</bold>. In the decoction,
water is used as a solvent with high polarity. This high polarity will cause
flavonoids to be attracted more during the extraction process<bold>27</bold>. The community has
widely used this decoction method to manufacture traditional medicines because
the extraction process is easy to do and does not require special tools. This
method was chosen because flavonoid compounds are readily soluble in water;
this property is influenced by the presence of OH groups in their structure
which causes flavonoids to have polar properties and can dissolve in polar
solvents. In addition, the infusion method, which is almost similar to decoct,
succeeded in extracting total flavonoids as measured by UV-Visible
spectrophotometry<bold>28</bold>.</p><p >The doses of MBP decoction
used for anti-inflammatory tests were 200, 400, and 800 mg/kg BW. In this
study, the moderate and low doses of 400 and 200 mg/kg BW were based on the
dose of ethanolic extract of the plant, one of which was the same species as
the M. balbisiana, specifically Musa acuminata, which had been
carried out by previous studies, in which these doses have been shown to
provide anti-inflammatory and analgesic effects<bold>29</bold>. In this study,
different test animals were used; the anti-inflammatory test was used by rats
because the paws of rats were more prominent, so it was easier to measure and
observe, while the analgesic test was used by mice because the mice were more
sensitive to pain than rats and the reaction of mice to pain was easier to
observe than mice<bold>30</bold>. Rats show more
complex reactions than mice due to higher brain function. These reactions are,
for example, sniffing, licking the soles of the feet, straightening the feet,
or other unknown reactions<bold>31</bold>.</p><p >In testing the
anti-inflammatory effect using the Winter method, the parameter used is the
decrease in the volume of edema in the soles of the mice (mL) compared to time
(hours). This method was chosen because it is a commonly used anti-inflammatory
test method, easy to perform, and can be measured quantitatively. Edema
formation was carried out using carrageenan as a chemical induction of
inflammation. Carrageenan was used because it did not cause injury or tissue
damage to the rat's paws<bold>32</bold>. Carrageenan is
more sensitive to anti-inflammatory drugs than other anti-irritants. In the
phases of edema formation, there is the release of mediators that initiate the
inflammatory process. The presence of edema formation phases also makes it
easier to see the work of the anti-inflammatory substances that were tested
more precisely, especially those that have a mechanism by inhibiting
prostaglandin biosynthesis and COX formation. Edema that develops can last for
six hours and gradually decrease over a day<bold>33</bold>.</p><p >The instrument used
in the anti-inflammatory test to measure the volume of edema in the soles of
the rat's feet was a plethysmometer connected to a burette. The liquid used is
mercury because mercury does not wet the rat's feet, and measurements are based
on Archimedes' law; if an object is placed in a liquid, it will exert an upward
force or pressure equal to the volume being pushed or moved. In the burette,
methylene blue liquid was used to make it easier to read at the time of
measurement, and the measurements were taken three times which were then
averaged. When measuring the other rat's paw, the right paw does not kick the
tool and interfere with the view when inserting the foot into the mercury<bold>34</bold>.</p><p >Anti-inflammatory
test studies were conducted on negative and positive controls and MBP decoction
of 200, 400, and 800 mg/kg BW. Before testing from the 1st to the 5th
hour (measurement of the volume of the rat's feet after carrageenan induction),
a test was conducted at the 0th hour (before carrageenan induction).
This was done to determine and ensure that the rat's feet were not swollen and
in normal condition. This test was only carried out for five hours because the
peak of edema that formed could not be observed. After all, the edema only
lasted for six hours before slowly healing<bold>35</bold>.</p><p >In the
anti-inflammatory test, it was found that the average volume of edema in the
negative control did not decrease the volume of edema in the rats' feet. In the
negative control, the treatment given to rats only gave aquadest so that there
was no inhibition of edema formation. Based on the average volume of edema in
the positive control and MBP decoction, there was a decrease in edema on the
soles of the rats. This happened because the positive control and MBP decoction
had inhibitory activity on edema formation<bold>36</bold>.</p><p >Anti-inflammatory
activity can also be seen from statistical testing of negative control with the
positive control, and MBP decoction for each dose showed a significant
difference. The decrease in edema volume in the positive control and the three
doses of MBP decoction occurred in the 3rd or 2nd hour
after carrageenan induction. This shows that diclofenac sodium and MBP
decoction inhibit edema formation because carrageenan induction can cause the
release of inflammatory mediators (prostaglandins) three hours after
carrageenan induction. This is also by the mechanism of action of diclofenac
sodium as an anti-inflammatory which works by inhibiting COX and prostaglandin
synthesis<bold>37</bold>.</p><p >The statistical
results of the positive control with MBP decoction of 200, 400, and 800 mg/kg
BW showed a significant difference, and this indicates that diclofenac sodium
as a positive control has better anti-inflammatory activity than the three
doses of MBP decoction. However, there was no significant difference in the three
doses of MBP decoction. This means that increasing doses of MBP decoction did
not affect the inhibitory activity of edema or anti-inflammatory activity. When
viewed from the AUC value of the average volume of the soles of the rat's paw,
a dose of 800 mg/kg BW gave a better anti-inflammatory effect than a dose of
200 and 400 mg/kg BW.</p><p >The method used for
the analgesic test used in this study is the Sigmund method; this method uses
chemical stimulation with glacial acetic acid. 3% glacial acetic acid, 0.2
mL/20 g BW, can induce mild pain in mice, as indicated by writhing. The choice
of this method is because this method is a simple method, easy to do, and
commonly used. This method is also more specific for drugs that are thought to
have prostaglandin inhibitory activity. The pain caused by glacial acetic acid
only lasts for an hour and then gradually subsides<bold>23</bold><bold>,</bold><bold>38</bold>. The parameter
measured in this method is the number of stretches of mice compared to time
(minutes). No different from the anti-inflammatory test in this test, the test
animals were fasted ± 18 hours before being given treatment; this was done so
that the stomach organ was empty and there was no food left so that the test
preparation that was absorbed by the body optimally was not disturbed by the
existing food. Symptoms seen in mice when they feel pain after administration
of acetic acid are characterized by contraction of the abdominal wall so that
the legs are pulled back, stretch, and the abdomen touches the base of the
space it occupies; this symptom is called writhing. This method's
administration of the preparation was carried out 30 minutes before induction
of glacial acetic acid and then observed for 60 minutes every five minutes.
This aims to see that the test preparation work provides a protective effect
against the pain caused by the inducer<bold>39</bold>.</p><p >In the analgesic
test, it was found that the average number of writhing of mice in the negative
control was more than the average number of stretches of the positive control
and preparations of MBP decoction at doses of 200, 400, and 800 mg/kg BW. This
happened because the negative control was only given aquadest so that there was
no inhibition of prostaglandin synthesis. On the other hand, the average number
of stretches decreased in the positive control and preparations of MBP decoction.
This shows that diclofenac sodium and the three doses of MBP decoction have
analgesic activity. In the statistical test, it can also be seen that there is
a significant difference between the negative control and the positive control
and the three doses of MBP decoction. It can also be stated that the activity
inhibits the synthesis of prostaglandins. This happens because acetic acid
induces pain by stimulating the release of free arachidonic acid from the
phospholipid tissue resulting in the formation of COX and prostaglandins so
that drugs that can reduce the number of mice writhing due to the induction of
glacial acetic acid can inhibit prostaglandin synthesis<bold>40</bold>. In the statistical
test, positive control with three doses of MBP decoction has a significant
difference, and this indicates that the positive control has better analgesic
activity than the three doses of MBP decoction. Then the increase in the dose
of MBP decoction at a dose of 200, 400, and 800 mg/kg BW showed that there was
a significant difference between the three doses, so it can be said that the
increase in the dose gave an increase in the analgesic effect.</p><p >In this study, the
decoction of MBP at a dose of 200, 400, and 800 mg/kg BW has been shown to have
% anti-inflammatory activity with 17.685; 25.53%; and 25.48%, and %
effectiveness with 51.35%; 74.15%; and 74.01%, respectively. Furthermore, MBP
decoction with a dose of 200, 400, and 800 mg/kg BW has an analgesic effect,
with the % inhibition of writhing in mice at 38.52%, 44.53%, and 49.31%, and %
effectiveness respectively 69.71%, 80.59%, and 89.24%. This finding is similar
to the study conducted by Yuei et al.<bold>29</bold> investigating
banana peels' anti-inflammatory and analgesic activity, especially the potency
of the popular Cavendish variety consumed. In their study, two different doses,
200 mg/kg and 400 mg/kg bark ethanol extract, were administered to rats by oral
administration. The hot plate test showed a good analgesic reaction for an
extract dose of 400 mg/kg rats treated at 60 minutes, comparable to a positive
control of diclofenac sodium. The anti-inflammatory test showed good
inflammatory action at six hours, comparable to positive control. The greatest
inhibition of inflammation was seen at six hours which was 63% in rats
receiving an extract dose of 400 mg/kg. These findings suggest that Cavendish
bark exhibits analgesic and anti-inflammatory activity. After the two tests
were carried out in this research, it could be seen that the MBP decoction had
anti-inflammatory and analgesic activity. The anti-inflammatory and analgesic
activity of MBP decoction involves the presence of compounds in the MBP which
are attracted when decoction, one of which is a flavonoid<bold>41</bold>. By inhibiting the arachidonic
acid metabolic pathway, the formation of prostaglandins, and the release of
histamine, flavonoids function as an anti-inflammatory or slow down the
inflammatory process<bold>42</bold>.</p>
			</sec><sec>
			<title>CONCLUSION</title>
				<p >The
decoction of the MBP at a dose of 200, 400, and 800 mg/kg BW could have an
inhibitory effect on edema on the soles of the rat's feet induced by 1%
carrageenan solution and exerted an inhibitory effect on the amount of writhing
in mice induced by acetic acid.</p>
			</sec><sec>
			<title>ACKNOWLEDGMENT</title>
				<p >We gratefully thanks to
Faculty Pharmacy of Universitas Pancasila for all support and facilities in
this study. This article was presented at the 5th International
Conference on Pharmaceutical Nanotechnology/Nanomedicine organized by the
Faculty of Pharmacy, Universitas Pancasila, Indonesia.</p>
			</sec><sec>
			<title>AUTHORS’ CONTRIBUTION</title>
				<p ><bold>Ni Made Dwi Sandhiutami</bold>: conceptualization, data curation, formal analysis, funding
acquisition, methodology, project administration, resources, supervision,
validation, and writing -review &amp; editing. <bold>Sondang Khairani</bold>: data
curation, formal analysis, methodology, supervision, validation. <bold>Rika Sari
Dewi</bold>: formal analysis, methodology, supervision, validation. <bold>Zainur
Rahman Hakim</bold>: supervision, validation, editing and writing -review &amp;
editing. <bold>Anita Rahmi Pradani</bold>: investigation, visualization, and writing
- original draft.</p>
			</sec><sec>
			<title>DATA AVAILABILITY</title>
				<p >None.</p>
			</sec><sec>
			<title>CONFLICT OF INTEREST</title>
				<p >The
authors declare there is no conflict of interest.</p>
			</sec><sec>
			<title>REFERENCES</title>
				<p >1.
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory
responses and inflammation-associated diseases in organs. Oncotarget.
2017;9(6):7204-18. doi:10.18632/oncotarget.23208</p><p >2.
Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee
MNM. The crucial roles of inflammatory mediators in inflammation: A review. Vet
World. 2018;11(5):627-35. doi:10.14202/vetworld.2018.627-635</p><p >3.
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of
Inflammation and Infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754</p><p >4.
Woolf CJ. What is this thing called pain? J Clin Invest.
2010;120(11):3742-4. doi:10.1172/jci45178</p><p >5. Sugimoto MA, Sousa LP, Pinho V, Perretti M,
Teixeira MM. Resolution of Inflammation:
What Controls Its Onset? Front Immunol. 2016;7:160. doi:10.3389/fimmu.2016.00160</p><p >6. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H,
Gibson S, et al. The revised International Association for the Study of Pain
definition of pain: concepts, challenges, and compromises. Pain.
2020;161(9):1976-82. doi:10.1097/j.pain.0000000000001939</p><p >7. Siler S, Borneman T, Ferrell B. Pain and
Suffering. Semin Oncol Nurs. 2019;35(3):310-4. doi:10.1016/j.soncn.2019.04.013</p><p >8. Wongrakpanich S, Wongrakpanich A, Melhado K,
Rangaswami J. A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug
Use in The Elderly. Aging Dis. 2018;9(1):143-50. doi:10.14336/ad.2017.0306</p><p >9. Gunaydin C, Bilge SS. Effects of Nonsteroidal
Anti-Inflammatory Drugs at the Molecular Level. Eurasian J Med. 2018;50(2):116-21.
doi:10.5152/eurasianjmed.2018.0010</p><p >10. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal
anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.
Biochem Pharmacol. 2020;180:114147. doi:10.1016/j.bcp.2020.114147</p><p >11. Yuan H, Ma Q, Ye L, Piao G. The Traditional
Medicine and Modern Medicine from Natural Products.Molecules. 2016;21(5):559.
doi:10.3390/molecules21050559</p><p >12. Sofowora A, Ogunbodede E, Onayade A. The role
and place of medicinal plants in the strategies for disease prevention. Afr J
Tradit Complement Altern Med. 2013;10(5):210-29. doi:10.4314/ajtcam.v10i5.2</p><p >13. Swargiary A, Boro H, Roy MK, Akram M. Phytochemistry
and Pharmacological Property of Musa balbisiana Colla: A Mini-Review.
Pharmacogn Rev. 2021;15(29):91-5. doi:10.5530/phrev.2021.15.11</p><p >14. Lumowa SVT, Bardin S. Uji Fitokimia Kulit Pisang
Kepok (Musa paradisiaca L.) Bahan Alam Sebagai Pestisida Nabati Berpotensi
Menekan Serangan Serangga Hama Tanaman Umur Pendek. J Sains Kesehatan.
2018;1(9):465-9. doi:10.25026/jsk.v1i9.87</p><p >15. Daimari M, Swargiary A. Study of Phytochemical
Content and Antioxidant Properties of Musa Balbisiana Corm Extract. Indian J
Pharm Sci. 2020;82(4):707-12. doi:10.36468/pharmaceutical-sciences.698</p><p >16. Phuaklee P, Ruangnoo S, Itharat A. Anti-inflammatory
and antioxidant activities of extracts from Musa sapientum peel. J Med Assoc
Thai. 2012;95(Suppl 1):S142-6.</p><p >17. Panchee AN, Diwan AD, Chandra SR. Flavonoids: an
overview. J Nutr Sci. 2016;5:e47. doi:10.1017/jns.2016.41</p><p >18. Yahfoufi N, Alsadi N, Jambi M, Matar C. The
Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients.
2018;10(11):1618. doi:10.3390/nu10111618</p><p >19. Nunes CDR, Arantes MB, Pereira SMdF, da Cruz LL,
Passos MdS, de Moraes LP, et al. Plants as Sources of Anti-Inflammatory Agents.
Molecules. 2020;25(16):3726. doi:10.3390/molecules25163726</p><p >20. Sharifi-Rad M, Kumar NAV, Zucca P, Varoni EM,
Dini L, Panzarini E, et al. Lifestyle, Oxidative Stress, and Antioxidants: Back
and Forth in the Pathophysiology of Chronic Diseases. Front Physiol.
2020;11:694. doi:10.3389/fphys.2020.00694</p><p >21. Carbone L, Austin J. Pain and Laboratory
Animals: Publication Practices for Better Data Reproducibility and Better
Animal Welfare. PLoS One. 2016;11(5):e0155001. doi:10.1371/journal.pone.0155001</p><p >22. Ganguly A, Al Mahmud Z, Uddin MMN, Rahman SMA. In-vivo
anti-inflammatory and anti-pyretic activities of Manilkara zapota leaves in albino
Wistar rats. Asian Pac J Trop Dis. 2013;3(4):301-7. doi:10.1016/S2222-1808(13)60073-0</p><p >23. Gawade SP. Acetic acid induced painful
endogenous infliction in writhing test on mice. J Pharmacol Pharmacother. 2012;3(4):348.
doi:10.4103/0976-500x.103699</p><p >24. McHugh ML. Multiple comparison analysis testing
in ANOVA. Biochem Med. 2011;21(3):203-9. doi:10.11613/bm.2011.029</p><p >25. Pereira A, Maraschin M. Banana (Musa spp) from
peel to pulp: Ethnopharmacology, source of bioactive compounds and its
relevance for human health. J Ethnopharmacol. 2015;160:149-63. doi:10.1016/j.jep.2014.11.008</p><p >26. Li L, Wang Y, Liu F, Xu Y, Bao H. Study on the
Effect of Deep Eutectic Solvent Liquid Phase Microextraction on Quality
Standard, Antitussive, and Expectorant of Sangbaipi Decoction. J Anal Methods
Chem. 2021;2021:9999406. doi:10.1155/2021/9999406</p><p >27. Abubakar AR, Haque M. Preparation of Medicinal
Plants: Basic Extraction and Fractionation Procedures for Experimental
Purposes. J Pharm Bioallied Sci. 2020;12(1):1-10. doi:10.4103/jpbs.jpbs_175_19</p><p >28. De Luna SLR, Ramírez-Garza RE, Saldivar SOS. Environmentally
Friendly Methods for Flavonoid Extraction from Plant Material: Impact of Their
Operating Conditions on Yield and Antioxidant Properties. Sci World J.
2020;2020:6792069. doi:10.1155/2020/6792069</p><p >29. Yuei LP, Singaram N, Hassan H. Study of
Anti-inflammatory and Analgesic Activity of Musa spp. Peel. ResearchGate: Preprint.
2016;46-53. doi:10.13140/RG.2.2.33612.10884</p><p >30. Deuis JR, Dvorakova LS, Vetter I. Methods Used
to Evaluate Pain Behaviors in Rodents. Front Mol Neurosci. 2017;10:284. doi:10.3389/fnmol.2017.00284</p><p >31. Regmi B, Shah MK. Possible implications of
animal models for the assessment of visceral pain. Animal Model Exp Med. 2020;3(3):215-28.
doi:10.1002/ame2.12130</p><p >32. Fehrenbacher JC, Vasko MR, Duarte DB. Models of
inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema
and hypersensitivity in the rat. Curr Protoc Pharmacol. 2012;5:5.4. doi:10.1002/0471141755.ph0504s56</p><p >33. Patil KR, Mahajan UB, Unger BS, Goyal SN,
Belemkar S, Surana SJ, et al. Animal Models of Inflammation for Screening of
Anti-inflammatory Drugs: Implications for the Discovery and Development of
Phytopharmaceuticals. Int J Mol Sci. 2019;20(18):4367. doi:10.3390/ijms20184367</p><p >34. Jijith US, Jayakumari S. An Apparatus for the
determination of rat paw Edema during In vivo Evaluation of Anti-inflammatory
agents. Res J Pharm Technol. 2020;13(5):2373-5. doi:10.5958/0974-360X.2020.00426.6</p><p >35. Sukmawati S, Yuliet Y, Hardani R. Uji Aktivitas
Antiinflamasi Ekstrak Etanol Daun Pisang Ambon (Musa paradisiaca L.) terhadap
Tikus Putih (Rattus norvegicus L.) yang Diinduksi Karagenan. J Farmasi Galenika
Galenika J Pharm. 2015;1(2):126-32. doi:10.22487/j24428744.2015.v1.i2.6244</p><p >36. Ayertey F, Ofori-Attah E, Antwi S, Amoa-Bosompem
M, Djameh G, Lartey NL, et al. Anti-inflammatory activity and mechanism of
action of ethanolic leaf extract of Morinda lucida Benth. J Tradit Complement
Med. 2020;11(3):249-58. doi:10.1016/j.jtcme.2020.07.001</p><p >37. Gan TJ. Diclofenac: an update on its mechanism
of action and safety profile. Curr Med Res Opin. 2010;26(7):1715-31. doi:10.1185/03007995.2010.486301</p><p >38. de la Puente B, Romero-Alejo E, Vela JM, Merlos
M, Zamanillo D, Portillo-Salido E. Changes in saccharin preference behavior as
a primary outcome to evaluate pain and analgesia in acetic acid-induced
visceral pain in mice. J Pain Res. 2015;8:663. doi:10.2147/jpr.s91230</p><p >39. Lavin DN, Joesting JJ, Chiu GS, Moon ML, Meng J,
Dilger RN, et al. Fasting induces an anti-inflammatory effect on the neuroimmune
system which a high-fat diet prevents. Obesity. 2011;19(8):1586-94. doi:10.1038/oby.2011.73</p><p >40. Faujdar S, Sharma S, Sati B, Pathak AK, Paliwal
SK. Comparative analysis of analgesic and anti-inflammatory activity of bark
and leaves of Acacia ferruginea DC. Beni-Suef Univ J Basic Appl Sci.
2016;5(1):70-8. doi:10.1016/j.bjbas.2016.02.002</p><p >41. Varalakshmi T, Hemalatha M, Sridevi K, Krishnan
SA, Manivasagam GA. In Vitro Evaluation of Anti-Oxidant and Anti-Inflammatory
Activity by using Ethanol Extract of Banana Peel. J Emerg Technol Innov Res.
2020;7(10):1671-8.</p><p >42. Bellik Y, Boukraâ L, Alzahrani HA, Bakhotmah BA,
Abdellah F, Hammoudi SM, et al. Molecular mechanism underlying
anti-inflammatory and anti-allergic activities of phytochemicals: an update.
Molecules. 2012;18(1):322-53. doi:10.3390/molecules18010322</p>
			</sec></body>
  <back>
    <ack>
      <p>We gratefully thanks to Faculty Pharmacy of Universitas Pancasila for all support and facilities in this study. This article was presented at the 5th International Conference on Pharmaceutical Nanotechnology/Nanomedicine organized by the Faculty of Pharmacy, Universitas Pancasila, Indonesia.</p>
    </ack>
  </back>
</article>